Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non Operating Income: 2018-2022

Historic Non Operating Income for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to -$12,080.

  • ADC Therapeutics' Non Operating Income rose 75.07% to -$9.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$22.3 million, marking a year-over-year decrease of 106.33%. This contributed to the annual value of -$12,080 for FY2022, which is 142.40% down from last year.
  • ADC Therapeutics' Non Operating Income amounted to -$12,080 in FY2022, which was down 142.40% from $28,489 recorded in FY2021.
  • ADC Therapeutics' Non Operating Income's 5-year high stood at $28,489 during FY2021, with a 5-year trough of -$22,606 in FY2020.
  • Its 3-year average for Non Operating Income is -$2,066, with a median of -$12,080 in 2022.
  • Its Non Operating Income has fluctuated over the past 5 years, first tumbled by 1,714.71% in 2020, then skyrocketed by 226.02% in 2021.
  • ADC Therapeutics' Non Operating Income (Yearly) stood at $3,069 in 2018, then crashed by 54.38% to $1,400 in 2019, then plummeted by 1,714.71% to -$22,606 in 2020, then surged by 226.02% to $28,489 in 2021, then tumbled by 142.40% to -$12,080 in 2022.